All Articles

Yuyu Pharma's quiet entry into the U.S. isn't just about cat supplements. It's a masterclass in strategic infiltration, using a UCLA incubator to de-risk a billion-dollar bet.

CAI Software's acquisition of LLumin isn't just another deal. It's a strategic move to build an integrated platform that tackles manufacturing's biggest cost.

The DermCare and USDP merger creates a dermatology behemoth. What does this consolidation mean for patients, doctors, and the future of specialized care?

A landmark survey reveals Republicans and Democrats in key states overwhelmingly agree on federal family support, challenging the narrative of a divided America.

ZincFive's SPAC merger isn't just a deal; it's a bet on the critical battery chemistry needed to sustain the world's insatiable AI power demands.

A new study shows AI is now standard in IT transformation. But as firms chase innovation, an old problem—poor data quality—threatens to derail progress.

A niche software firm just unlocked the federal market in weeks, not years. Their secret weapon? An AI platform that turns a dreaded security gauntlet into a strategic advantage.

Unanimous AI's new Hyperlingual platform enables real-time, multi-language debates, promising to unlock global collaboration and trapped economic value.

With its new Bogotá center, Auxis taps into Colombia's booming bilingual talent pool, offering U.S. businesses a resilient alternative to far-flung operations.

Two firms unite to form Endure, a national platform for critical power. They promise seamless service, but in a world reliant on data, the real test is just beginning.

Landing on the Inc. 5000 is just the headline. The real story is how iScribeHealth's ambient AI is tackling healthcare's $43B paperwork crisis.

Air India is using AI to ask passengers to switch flights for perks. It's a key part of its massive turnaround, turning overbooking from a headache into a choice.

A Kansas City CCRC's pivot from hefty entrance fees to a rental model reveals a strategic play by new owner Lapis Advisers, a blueprint for the industry.

A landmark study proves the link between environmental action and financial performance is not direct, but flows through a powerful new channel: consumer sales.

Advanced Flower Capital's Q2 saw Net Asset Value rise, thanks to a savvy share buyback. But a drop in net investment income reveals a complex transition.

Q2 data reveals a stark divergence: private markets show steady, earnings-driven growth while public markets chase AI hype. But beneath the surface, a new era of selectivity emerges.

NeuPath Health's Q2 results show headline declines, but a deeper look reveals strong organic growth from record patient visits and strategic expansion.

Revenue is down, but Bragg Gaming's margins are up. A new chairman, a major acquisition, and deep cuts signal a high-stakes bet on a leaner future.

MSG Sports posts record profits fueled by a Knicks NBA title, but the real story is the strategic gamble to split its empire, creating long-term risks.

NervGen Pharma launches its pivotal Phase 3 RESTORE trial for spinal cord injury, backed by $61M in cash and new leadership, igniting hope for a new era of neuro-repair.